Ground Truth Labs
Mission
Improve outcomes for every cancer patient with AI driven insights from digital pathology.
Team
Our interdisciplinary team brings together a wealth of experience in artificial intelligence, clinical pathology, oncology, and biomarker development, ensuring a comprehensive approach to solving your complex problems.
Alan Aberdeen
Co-founder & CEO
Alan co-founded GTL in 2019 with Korsuk and Jens. He brings expertise in software and machine learning, with an academic background in Engineering at Oxford and HCI studies in Paris and Berlin.
Korsuk Sirinukunwattana
Co-founder & CTO
Korsuk leads AI and computational pathology development, drawing on research experience as a post-doctoral fellow at Oxford, Harvard, and Stanford.
Jens Rittscher
Co-founder & CSO
Jens steers our scientific direction, leading the Quantitative Biological Imaging group at Oxford and Charité, and bringing prior experience leading computer vision research at General Electric.
Saad Bashir
Machine Learning Scientist
Saad develops new machine learning models for computational pathology, building on his PhD from the University of Warwick.
Vasco Ferreira Pinto
Head of Strategy and Operations
Vasco oversees strategy and operations, with a decade of experience in biotech, diagnostics, and biopharma services.
Ka Ho Tam
Software Engineer
Ka Ho builds our web platform, applying his expertise from a DPhil at Oxford in machine learning and histopathology.
Sam Maxwell
Software Engineer
Sam builds robust, scalable software platforms, leveraging his MSc in Biomedical Engineering and expertise in software engineering for fintech and healthcare.
Xuezi Hu
Machine Learning Scientist
Xuezi develops AI models for computational biology, building on experience in geophysical imaging. She has degrees in mathematics and systems biology from the University of Cambridge.
Ruoyu Wang
Machine Learning Scientist
Ruoyu specializes in machine learning and computational pathology, he is finalizing his PhD in Computer Science at Warwick.
Anna Kotanska
Quality & Product Associate
Anna leads Product and Quality, and supports technical operations. She has a background in chemistry from Oxford and computer vision research at the Crick Institute.
Celina Wierzbicka
Frontend Engineer
Celina builds responsive web applications, combining a PhD in Biomedical Science with extensive experience in user-focused web development.
Sharon Ruane
VP Research Partnerships
Sharon leads research partnerships, leveraging her expertise in AI for biomedicine. She holds a PhD in Chromosome and Developmental Biology from Oxford.
We're hiring
Join us to build on the latest research in AI and digital pathology.
Clinical
Dr Daniel Royston
Pathology Lead
Daniel Royston is a leading haematopathologist in clinical and research globally. He is a practising Consultant at the Oxford University Hospital with a vast list of contributions to research in the field of specialty cancers, particularly advancing global knowledge of MPNs.
Prof Tim Maughan
Oncology
Tim Maughan is Professor of Clinical Oncology at the University of Oxford and CEO of the National Cancer Research Institute. He was the founding chair of the NCRI Clinical and Translational Radiotherapy Research Working Group, which has a broad remit to enhance radiotherapy research in the UK.
Prof Viktor Koelzer
Pathology
Prof. Viktor Koelzer holds the first professorship for digital pathology in Switzerland with the key strategic aim of digitalization of clinical pathology diagnostics and research at the University Hospital Zurich.
Advisors
Vincent Fert
Advisor
Vincent is an accomplished executive in the diagnostics industry and a seasoned entrepreneur. He founded HalioDX, and under his leadership as Chairman and CEO, he successfully expanded the company until its prosperous acquisition by Veracyte.
Dr Liliane Chamas
Board member
Liliane has over a decade of experience across genetics research and digital innovation in health systems. Bringing to GTL a track record of deploying digital solutions to address health issues on a global scale.
Dr Heather Roxborough
Advisor
Heather is a highly experienced venture capitalist, with over 20 years investment and company building experience in health tech and consumer healthcare.